4.6 Article Proceedings Paper

Preventing chronic obstructive pulmonary disease: What is known and what needs to be done to make a difference to the patient?

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 120, Issue 8, Pages S14-S22

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2007.04.008

Keywords

chronic obstructive pulmonary disease; guidelines; smoking cessation; spirometry; systemic effects

Ask authors/readers for more resources

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable systemic disease with symptoms that overlap other respiratory illnesses. An estimated 24 million adults in the United States have COPD, but > 50% of them are misdiagnosed or undiagnosed. Spirometry remains the gold standard for diagnosing COPD and for monitoring the progression of the disease. Cigarette smoking is the main cause of COPD; therefore, smoking cessation is an integral component of any program to reduce COPD risk and delay or limit the progression of airflow obstruction. Influenza vaccinations will also reduce acute respiratory illness in patients with COPD. With increasing awareness of COPD and earlier diagnosis, implementation of treatment guidelines and smoking-cessation efforts may lead to more effective management of this disease, which is projected to be the third leading cause of death in the United States by 2020. (c) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available